StandardAero valued at $10.4 billion as shares jump in NYSE debut-August 2024-www.financetom.com

StandardAero valued at $10.4 billion as shares jump in NYSE debut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

StandardAero valued at $10.4 billion as shares jump in NYSE debut

Oct 2, 2024 11:14 PM

(Reuters) - StandardAero's ( SARO ) shares opened 29% above the initial public offering price in their market debut on Wednesday, giving the Carlyle-backed aviation maintenance services provider a market value of about $10.4 billion.

(Reporting by Niket Nishant and Prakhar Srivastava in Bengaluru; Editing by Sriraj Kalluvila)

Previous page： 3M's Q2 Adjusted Earnings Increase, Net Sales Decline Next page： --Select Water Solutions Keeps Dividend at $0.06 per Class A Share, Payable Aug. 16 to Holders as of Aug. 5

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

3M's Q2 Adjusted Earnings Increase, Net Sales Decline

Jul 26, 2024

06:58 AM EDT, 07/26/2024 (MT Newswires) -- 3M ( MMM ) reported Q2 adjusted earnings Friday of $1.93 per diluted share, up from $1.39 a year earlier. Analysts polled by Capital IQ expected $1.68. Net sales for the quarter ended June 30 were $6.26 billion compared with $6.28 billion a year earlier. Analysts polled by Capital IQ expected $5.83 billion....

--Select Water Solutions Keeps Dividend at $0.06 per Class A Share, Payable Aug. 16 to Holders as of Aug. 5

Jul 26, 2024

05:27 AM EDT, 07/26/2024 (MT Newswires) -- Price: 11.49, Change: +0.26, Percent Change: +2.29 ...

Barnes Group Q2 Adjusted Earnings Fall, Revenue Increase; Lowers Fiscal 2024 Adjusted Earnings Guidance

Jul 26, 2024

06:57 AM EDT, 07/26/2024 (MT Newswires) -- Barnes Group ( B ) reported Q2 adjusted earnings Friday of $0.37 per diluted share, down from $0.58 a year earlier. Four analysts polled by Capital IQ expected $0.40. Revenue for the quarter ended June 30 was $382.2 million compared with $339 million a year earlier. Four analysts surveyed by Capital IQ expected...

Bristol Myers second-quarter results beat expectations, helped by new drugs

Jul 26, 2024

July 26 (Reuters) - Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis. The company also raised its earnings forecast for the full year. You're really seeing the transformation of our business to the new growth portfolio, Chief...